Top-News

SWK Holdings Corp News

Keine aktuellen Kursdaten verfügbar
WKN: A0RN93
ISIN: US78501P1049
Typ: Aktie

SWK Holdings Corp News

13.06.22 - PR Newswire
Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference
Enteris BioPharma Presents Data from Two Clinical Studies Involving Oral Formulations of Leuprolide at ENDO 2022 Annual Conference PR Newswire
07.06.22 - PR Newswire
Enteris BioPharma Publishes White Paper Examining Safe Handling and Manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPI)
Enteris BioPharma Publishes White Paper Examining Safe Handling and Manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPI) PR Newswire
26.05.22 - PR Newswire
Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022
Enteris Employees Lend Ronald McDonald House a Helping Hand at Enteris Day 2022 PR Newswire
19.05.22 - PR Newswire
SWK Holdings Corporation Announces Filing of Form S-3 Shelf Registration Statement
SWK Holdings Corporation Announces Filing of Form S-3 Shelf Registration Statement PR Newswire
11.05.22 - PR Newswire
/C O R R E C T I O N -- SWK Holdings Corporation/
/C O R R E C T I O N -- SWK Holdings Corporation/ PR Newswire
10.05.22 - PR Newswire
SWK Holdings Corporation to Report First Quarter 2022 Financial Results
SWK Holdings Corporation to Report First Quarter 2022 Financial Results PR Newswire
04.05.22 - PR Newswire
Enteris BioPharma to Exhibit at CPhI North America 2022
Enteris BioPharma to Exhibit at CPhI North America 2022 PR Newswire
12.04.22 - PR Newswire
Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference
Enteris BioPharma Announces Acceptance of Two Abstracts for Presentation at ENDO 2022 Annual Conference PR Newswire
04.04.22 - PR Newswire
Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innovative Technologies for Improving Drug Solubility and Bioavailability
Enteris BioPharma Highlighted as Game Changer in Drug Development & Delivery Special Feature on Innovative Technologies for Improving Drug Solubility and Bioavailability PR ...
28.03.22 - PR Newswire
SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2021
SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2021 PR Newswire
25.03.22 - PR Newswire
AOTI Secures Major Expansion Funding from Leading Healthcare Financier
AOTI Secures Major Expansion Funding from Leading Healthcare Financier PR Newswire
23.03.22 - PR Newswire
SWK Holdings to Participate in Maxim's 2022 Virtual Growth Conference
SWK Holdings to Participate in Maxim's 2022 Virtual Growth Conference PR Newswire
07.03.22 - PR Newswire
Enteris BioPharma Publishes White Paper on Best Practices for Ensuring Content Uniformity in Solid Oral Dosage Manufacturing with HPAPI
Enteris BioPharma Publishes White Paper on Best Practices for Ensuring Content Uniformity in Solid Oral Dosage Manufacturing with HPAPI Paper examines barriers to achieving ...
02.03.22 - PR Newswire
Enteris BioPharma to Participate in DCAT® Week 2022
Enteris BioPharma to Participate in DCAT® Week 2022 PR Newswire
16.02.22 - PR Newswire
SWK Holdings Announces Reconstitution of Board of Directors with New Appointments
SWK Holdings Announces Reconstitution of Board of Directors with New Appointments PR Newswire
09.02.22 - PR Newswire
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements Fourth Quarter 2021 Financial Results to be Announced in March PR Newswire
05.01.22 - PR Newswire
Special Committee Concludes Review of Non-Binding Proposal from Carlson Capital
Special Committee Concludes Review of Non-​Binding Proposal from Carlson Capital PR Newswire
05.01.22 - PR Newswire
Enteris BioPharma Highlights 2021 Achievements and 2022 Outlook
Enteris BioPharma Highlights 2021 Achievements and 2022 Outlook Enteris continues to capitalize on multiple value building opportunities involving Peptelligence® and ...
20.12.21 - PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Sale of SWK Holdings Corporation to Carlson Capital, L.P.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation into the Fairness of the Sale of SWK Holdings Corporation to Carlson Capital, L.P. PR Newswire
20.12.21 - PR Newswire
Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During "J.P. Morgan Week 2022"
Enteris BioPharma to Participate in Biotech Showcase Virtual and BIO Partnering at JPM During "J.P. Morgan Week 2022" PR Newswire

Newssuche

Videos

newspaper
09:30 Uhr +34,15%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »